Weight gain in Namibians with HIV switching from efavirenz to dolutegravir.

David M HacheyIrene van WoerdenRoselli ShiluamaBonifasius Siyuka Singu

Published in: International journal of STD & AIDS (2023)

Females living with HIV in Namibia gain weight when switched from TEE to TLD. Clinical implications on the development of cardiometabolic complications is unclear and mechanisms by which the weight gain occurs are unknown.

Keyphrases

weight gain
antiretroviral therapy
hiv infected
body mass index
hiv infected patients
hiv positive
human immunodeficiency virus
birth weight
hiv aids
weight loss
hiv testing
risk factors
hepatitis c virus
physical activity
men who have sex with men
preterm birth
body weight